In summary, this study demonstrates for the first time that administration of tryptamine attenuates a murine model of MS by suppressing neuroinflammation and adds to the growing dataset demonstrating that microbial metabolism within the GI tract plays an important role in regulating neuroinflammation through the production of AHR ligands. The gene discussed is AHR; the disease is myeloid sarcoma.